NYSE:WATLife Sciences
Waters (WAT) Following Recurring Revenue Momentum Is It Still Undervalued
Why Waters Is Back in Focus for Investors
Waters (WAT) is back on investor radar as its role in supplying analytical instruments and software links directly to accelerating recurring revenues, higher service plan uptake, and growing e-commerce activity, with margins also under review.
See our latest analysis for Waters.
At a share price of US$374.68, Waters has seen a 24.59% 90 day share price return and a 23.92% 1 year total shareholder return, signalling building momentum as investors...